TY  - GEN
AU  - Walker,Alison R
AU  - Wang,Hongyan
AU  - Walsh,Katherine
AU  - Bhatnagar,Bhavana
AU  - Vasu,Sumithira
AU  - Garzon,Ramiro
AU  - Canning,Renee
AU  - Geyer,Susan
AU  - Wu,Yue-Zhong
AU  - Devine,Steven M
AU  - Klisovic,Rebecca
AU  - Blum,William
AU  - Marcucci,Guido
TI  - Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia
SN  - 1029-2403
PY  - 2018///0112
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Bortezomib
KW  - Chromosome Aberrations
KW  - Cytarabine
KW  - Drug Monitoring
KW  - Drug Resistance, Neoplasm
KW  - Etoposide
KW  - Female
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - diagnosis
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Mitoxantrone
KW  - Recurrence
KW  - Remission Induction
KW  - Retreatment
KW  - Staurosporine
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3109/10428194.2015.1135435
ER  -